VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
EMN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
EMNEastman Chemical Company
$64.41$7.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksEMNCash Flow

Eastman Chemical Company (EMN) Cash Flow Statement

30Y historyFree accessUpdated daily

Free cash flow margin recovered from -11.0% in 2026Q1 to 8.2% in 2026Q3 with operating cash flow at 1.15 to 1.22 times net income in the latest two quarters, though working capital swings of $370M outflow and $137M inflow indicate uneven conversion.

Income StatementBalance SheetCash FlowRatios

EMN Cash Flow Statement

Annual statement

EMN Cash Flow Statement

Eastman Chemical Company (EMN) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations879M970M1.29B1.37B975M1.62B1.46B1.5B1.54B1.66B1.39B1.62B1.43B1.3B1.13B625M575M758M653M732M609M769M494M244M801M397M846M744M731M698M746M
Operating CF Margin %-11.08%13.72%14.94%9.25%15.44%17.19%16.26%15.24%17.42%15.48%16.99%15.07%13.86%13.99%8.71%9.92%15.09%9.71%10.72%8.17%10.89%7.51%4.21%15.06%7.37%15.99%16.21%16.31%14.92%15.6%
Operating CF Growth %-20.8%-24.63%-6.33%40.92%-39.78%11.27%-3.26%-2.53%-6.88%19.64%-14.72%13.33%10.49%14.98%80.48%8.7%-24.14%16.08%-10.79%20.2%-20.81%55.67%102.46%-69.54%101.76%-53.07%13.71%1.78%4.73%-6.43%-10.98%
Net Income647M474M908M896M796M867M489M762M1.08B1.39B859M854M757M1.17B444M647M427M136M346M300M409M557M170M-270M61M-175M303M48M249M286M380M
Depreciation & Amortization528M513M509M498M477M538M574M611M604M587M580M571M450M433M360M273M280M274M267M327M308M304M322M367M397M435M418M383M351M327M314M
Stock-Based Compensation-49M000000000000000000000000000000
Deferred Taxes167M141M-52M-102M-136M-38M-111M23M-51M-394M177M107M99M331M48M-22M47M185M-71M-9M7M115M-136M-140M95M-78M67M-18M66M7M8M
Other Non-Cash Items78M28M-49M-209M-175M279M338M134M-21M-67M-138M76M202M-422M222M-11M172M179M-13M130M-12M-115M118M464M27M378M-29M79M33M00
Working Capital Changes-492M-186M-29M291M13M-27M165M-26M-73M143M-93M16M-75M-217M54M-262M-351M-16M124M-16M-103M-92M20M-177M221M-163M87M252M32M78M44M
Change in Receivables-140M61M28M126M93M-281M-31M170M16M-53M-29M114M19M-38M48M-73M-358M2M261M-28M-82M60M-133M-46M0000000
Change in Inventory-278M24M-344M201M-430M-389M291M-80M-224M-71M55M-26M-61M-6M38M-156M-160M100M-95M66M-99M-110M18M41M-58M-8M-43M63M19M-65M10M
Change in Payables199M-76M188M-190M60M554M-100M-27M90M123M7M-102M-30M-2M10M-51M152M16M-211M000000000000
Cash from Investing-346M-462M-534M-432M392M-29M-394M-480M-463M-643M-655M-693M-4.09B-457M-2.96B-142M-442M-369M-376M-335M-94M-18M-148M-160M-467M-523M-465M-715M-545M-745M-809M
Capital Expenditures-410M-546M-599M-828M-611M-555M-383M-425M-528M-649M-626M-652M-593M-483M-465M-457M-243M-310M-634M-529M-405M-343M-248M-230M-427M-234M-226M-292M-500M-749M-789M
CapEx % of Revenue4.53%6.24%6.38%9%5.8%5.29%4.52%4.6%5.22%6.82%7%6.82%6.23%5.16%5.77%6.37%4.19%6.17%9.43%7.75%5.44%4.86%3.77%3.97%8.03%4.34%4.27%6.36%11.16%16.01%16.5%
Acquisitions38M38M38M379M997M553M-1M-48M-3M-4M-26M-41M-3.51B0-2.67B-156M-190M-68M-38M-40M000-15M-6M-257M-261M-381M-27M0-26M
Investments-------------------------------
Other Investing26M46M27M17M6M-27M-10M-7M68M10M-3M011M26M-28M671M-9M-21M-41M234M311M-92M100M85M-34M-32M10M-42M-18M4M6M
Cash from Financing-258M-797M-454M-888M-1.32B-1.69B-704M-1.04B-1.04B-1.01B-838M-844M2.64B-859M1.5B-423M-411M18M-779M-448M-101M-547M-579M397M-323M91M-466M128M-186M52M-13M
Debt Issued (Net)154M-304M198M-338M76M-350M-307M-370M-316M-369M-428M-505M3.25B-530M1.64B-37M-122M150M-182M-22M-50M-505M-519M529M-187M210M-278M314M-66M191M273M
Equity Issued (Net)0-100M-300M-150M-1B-1B-60M-325M-400M-350M-145M-103M-410M-238M0-316M-280M-21M-501M-279M93M100M77M0-1M16M-53M-51M0-8M-161M
Dividends Paid-382M-381M-379M-376M-381M-375M-358M-343M-318M-296M-272M-238M-210M-140M-192M-136M-127M-128M-135M-147M-144M-142M-137M-136M-135M-135M-135M-138M-138M-138M-134M
Share Repurchases0-100M-300M-150M-1B-1B-60M-325M-400M-350M-145M-103M-410M-238M0-316M-280M-21M-501M-382M0000-1M-4M-57M-51M0-8M-161M
Other Financing-30M-12M27M-24M-14M35M21M-5M-6M9M7M2M9M49M52M66M118M17M39M00004M0003M18M7M9M
Net Change in Cash279M-271M289M55M34M-105M360M-22M35M10M-112M79M-23M-12M-328M61M-277M406M-501M-51M415M199M-233M481M11M-35M-85M157M05M-76M
Free Cash Flow469M424M688M546M364M1.04B1.06B1.07B1.01B1.01B759M972M840M814M658M159M325M440M9M203M204M426M246M14M374M163M620M452M231M-51M-43M
FCF Margin %5.18%4.84%7.33%5.94%3.46%9.93%12.51%11.6%10.03%10.59%8.49%10.17%8.83%8.7%8.16%2.22%5.61%8.76%0.13%2.97%2.74%6.03%3.74%0.24%7.03%3.02%11.72%9.85%5.16%-1.09%-0.9%
FCF Growth %17.54%-38.37%26.01%50%-65.03%-1.7%-1.3%5.71%0.69%32.81%-21.91%15.71%3.19%23.71%313.84%-51.08%-26.14%4788.89%-95.57%-0.49%-52.11%73.17%1657.14%-96.26%129.45%-73.71%37.17%95.67%552.94%-18.6%-110.97%
FCF per Share4.073.675.844.572.917.597.767.757.106.905.116.495.565.204.411.112.202.990.061.211.222.601.570.092.421.064.032.871.45-0.32-0.27
FCF Conversion (FCF/Net Income)0.72x2.05x1.42x1.54x1.23x1.89x3.04x1.98x1.43x1.12x1.60x1.92x1.91x1.11x2.58x0.90x1.31x5.57x1.89x2.44x1.49x1.38x2.91x-0.90x13.13x-2.22x2.79x15.50x2.94x2.44x1.96x
Interest Paid000214M000000000000000000000000000
Taxes Paid0000000000000000000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Working capital-driven cash volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Earnings Converting Erratically Into Operating Cash

Based on EMN's reported quarterly figures, operating cash flow ran at 1.15 to 1.22 times net income in the two most recent quarters but was negative in 2026Q1 and 2025Q1 despite positive reported earnings.

The gap between net income and operating cash flow is the central signal here, and the swings from negative to strongly positive operating cash flow point to working capital timing rather than a stable earnings base. The unusually high ratios in 2025Q3 and 2025Q4 suggest net income was temporarily depressed while cash was released from receivables or inventory, which means the strongest cash quarters may not be repeatable. Investors should monitor whether conversion normalizes near 1.0 times over a full cycle, since the current pattern does not yet confirm durable earnings quality.

Working Capital Drives Quarterly Cash Volatility

As reported in financial statements, EMN's working capital changes swung from a $370M outflow in 2026Q1 to a $137M inflow in 2025Q4, accounting for most of the quarterly operating cash variance.

These swings are large relative to quarterly net income of $47M to $330M, indicating that receivables, inventory, and payables are the dominant determinant of reported operating cash flow. The pattern of heavy outflows in Q1 periods followed by inflows in Q4 suggests a recurring seasonal build and release cycle that may reflect inventory positioning ahead of demand. Investors should track whether these reversals fully unwind over each annual period, as persistent net outflows would indicate deteriorating collection or inventory efficiency.

Free Cash Flow Recovering From Negative Base

Based on EMN's reported figures, free cash flow margin improved from negative 11.0% in 2026Q1 to 8.2% in 2026Q3, though the trend remains uneven relative to 2024 levels of 10.5% to 16.3%.

The recent rebound is meaningful, but it follows two negative free cash flow quarters, so the current level should be read as recovery from a weak base rather than a new trend. Compared with 2024, free cash flow margins remain lower, which is consistent with the negative year-over-year revenue trajectory and softer volume. Investors should monitor whether two consecutive positive quarters persist once working capital tailwinds fade.

Capex Discipline Under Revenue Pressure

According to recent SEC filings, EMN's capital expenditures have run at roughly 4.0% to 8.0% of revenue, with the ratio falling to 4.0% in the latest two quarters from peaks near 8.0% in 2024Q4.

Capital intensity is moderating as spending has been reduced in absolute dollars, from $179M in 2024Q4 to about $95M to $100M recently, which may reflect deliberate pacing of growth projects. Capex has remained close to depreciation at roughly $130M per quarter, suggesting the company is largely reinvesting to sustain the existing asset base rather than expanding it. The circular economy facilities warrant scrutiny, since separating maintenance from growth spending will determine the true underlying free cash flow of the legacy business.

Dividend Commitment Absorbs Recovered Cash

Based on EMN's reported cash flows, dividends have been steady at about $94M to $96M per quarter, while buybacks and acquisitions have been intermittent, with the last $50M buyback in 2025Q2 and a $38M acquisition outflow in 2025Q4.

Shareholder distributions have been consistent even during quarters of negative free cash flow, which implies dividends were funded from balance sheet resources or working capital releases in weaker periods. The absence of recent repurchases after 2025 suggests management is prioritizing the dividend and capital preservation while revenue remains under pressure. Investors should monitor whether the dividend remains covered by free cash flow over a full annual period, as coverage in weak quarters appears thin.

Recovery Case Rests on Two Quarters

Based on EMN's reported quarterly cash flows, the case for sustained cash generation depends on two consecutive positive quarters, which is a short window given the -6.7% trailing revenue trend and prior negative free cash flow periods.

The 2026Q2 and 2026Q3 operating cash inflows may be partly driven by working capital release following the large 2026Q1 outflow of $370M, rather than by a structural improvement in earnings quality. If that release reverses, free cash flow could return to negative territory even with stable reported net income. Investors should treat the recent rebound as provisional until working capital stabilizes and conversion holds near 1.0 times across a full annual cycle.

EMN — Frequently Asked Questions

Quick answers to the most common questions about buying EMN stock.

How much cash does Eastman Chemical Company (EMN) generate from operations?

Eastman Chemical Company (EMN) generated $970.0M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Eastman Chemical Company's free cash flow?

Eastman Chemical Company (EMN) generated $424.0M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Eastman Chemical Company's capital expenditure (CapEx)?

Eastman Chemical Company (EMN) spent $546.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Eastman Chemical Company distribute cash to shareholders?

In 2025, Eastman Chemical Company (EMN) returned $381.0M to shareholders via cash dividends and spent $100.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.